American Financial Group’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $135K | Hold |
|
|||||
|
2025
Q1 | $103K | Hold |
|
|||||
|
2024
Q4 | $160K | Hold |
|
|||||
|
2024
Q3 | $587K | Hold |
|
|||||
|
2024
Q2 | $462K | Hold |
|
|||||
|
2024
Q1 | $669K | Hold |
|
|||||
|
2023
Q4 | $402K | Hold |
|
|||||
|
2023
Q3 | $322K | Hold |
|
|||||
|
2023
Q2 | $406K | Hold |
|
|||||
|
2023
Q1 | $431K | Hold |
|
|||||
|
2022
Q4 | $485K | Hold |
|
|||||
|
2022
Q3 | $380K | Hold |
|
|||||
|
2022
Q2 | $279K | Hold |
|
|||||
|
2022
Q1 | $550K | Hold |
|
|||||
|
2021
Q4 | $591K | Hold |
|
|||||
|
2021
Q3 | $400K | Hold |
|
|||||
|
2021
Q2 | $429K | Buy |
|